Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Eltanexor

🥰Excellent
Catalog No. T11766LCas No. 1642300-52-4
Alias ONO-7706, KPT-8602, ATG-016

Eltanexor (ONO-7706) is an orally active exportin-1 (XPO1) inhibitor. It has effective anti-leukemic activity. Eltanexor inhibits XPO1-dependent nuclear export (EC50=60.9 nM) by directly targeting XPO1. Eltanexor causes caspase-dependent apoptosis in a panel of leukemic cell lines.

Eltanexor

Eltanexor

🥰Excellent
Purity: 99.76%
Catalog No. T11766LAlias ONO-7706, KPT-8602, ATG-016Cas No. 1642300-52-4
Eltanexor (ONO-7706) is an orally active exportin-1 (XPO1) inhibitor. It has effective anti-leukemic activity. Eltanexor inhibits XPO1-dependent nuclear export (EC50=60.9 nM) by directly targeting XPO1. Eltanexor causes caspase-dependent apoptosis in a panel of leukemic cell lines.
Pack SizePriceAvailabilityQuantity
1 mg$60In Stock
2 mg$108In Stock
5 mg$237In Stock
10 mg$282In Stock
25 mg$466In Stock
50 mg$662In Stock
100 mg$959In Stock
500 mg$1,920In Stock
1 mL x 10 mM (in DMSO)$223In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Eltanexor"

Select Batch
Purity:99.76%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Eltanexor (ONO-7706) is an orally active exportin-1 (XPO1) inhibitor. It has effective anti-leukemic activity. Eltanexor inhibits XPO1-dependent nuclear export (EC50=60.9 nM) by directly targeting XPO1. Eltanexor causes caspase-dependent apoptosis in a panel of leukemic cell lines.
Targets&IC50
XPO1:60.9 nM(EC50)
In vitro
Eltanexor (KPT-8602) (1 nM; 16 hours) causes apoptosis in leukemia cell lines. KPT-8602 (2-6 nM; 72 hours) decreases cell viability in leukemia cell lines (EC50s ranging from 25 to 145 nM).
In vivo
KPT-8602 (15 mg/kg; oral gavage; daily for 12 days) demonstrates potent anti-lymphoblastic leukemia activity.
AliasONO-7706, KPT-8602, ATG-016
Chemical Properties
Molecular Weight428.29
FormulaC17H10F6N6O
Cas No.1642300-52-4
SmilesNC(=O)C(=C\n1cnc(n1)-c1cc(cc(c1)C(F)(F)F)C(F)(F)F)\c1cncnc1
Relative Density.1.57 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (186.78 mM)
H2O: < 0.1 mg/mL (insoluble)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3349 mL11.6743 mL23.3487 mL116.7433 mL
5 mM0.4670 mL2.3349 mL4.6697 mL23.3487 mL
10 mM0.2335 mL1.1674 mL2.3349 mL11.6743 mL
20 mM0.1167 mL0.5837 mL1.1674 mL5.8372 mL
50 mM0.0467 mL0.2335 mL0.4670 mL2.3349 mL
100 mM0.0233 mL0.1167 mL0.2335 mL1.1674 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Eltanexor | purchase Eltanexor | Eltanexor cost | order Eltanexor | Eltanexor chemical structure | Eltanexor in vivo | Eltanexor in vitro | Eltanexor formula | Eltanexor molecular weight